REPEAT TRANSURETHRAL RESECTION OF THE BLADDER AND THE RESULTS OF TREATMENT IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER

A comprehensive analysis was made to study whether it was expedient to use repeat transurethral resection (TUR) of the bladder to treat patients with non-muscle invasive bladder cancer (NMIBC) in routine practice, by clarifying the impact of repeat TUR of the bladder on relapse-free survival time and estimating the prognostic value of this procedure. A prospective study enrolled 2 groups of patients with NMIBC (Т1NxM0 G1 3) made up according to the scope of surgical treatment (single and repeat TUR of the bladder) with a median follow-up of 26 months. The therapeutic effect of TUR carried out 4-6 weeks after primary TUR was noted only in patients at low and moderate risk for recurrence. The possibilities of using repeat TUR are also shown to predict risk for early recurrence and to choose the optimal surgical policy for patients with NMIBC, which make it possible to recommend its incorporation into routine clinical practice.